Cargando…
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation
α-Synuclein (α-Syn) aggregates are implicated in Parkinson’s disease (PD), so inhibitors of α-Syn aggregation have been intensively explored. It has been demonstrated that small molecules might be able to reduce α-Syn aggregation in fibrils, thus exerting neuroprotective effects in models of PD. To...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738895/ https://www.ncbi.nlm.nih.gov/pubmed/36499173 http://dx.doi.org/10.3390/ijms232314844 |